Lymphoproliferative Disorder
📧 Sign up to get email alerts when something new happens for Lymphoproliferative Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas [Phase 2]
Phase 2 clinical trial evaluating nivolumab in Epstein-Barr virus–positive lymphoproliferative disorders and EBV-positive non-Hodgkin lympho…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE [Phase 1]
Phase 1 trial evaluating EBV-specific cytotoxic T lymphocytes (GRALE) for EBV-positive lymphomas, currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Acalabrutinib and Obinutuzumab for the Treatment of Previously Untreated Follicular Lymphoma or Other Indolent Non-Hodgkin Lymphomas [Phase 2]
A Phase 2 clinical trial evaluating the combination of acalabrutinib and obinutuzumab as initial therapy for previously untreated follicular…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD) [NA]
A clinical trial updating on the mechanisms of clonal and non-clonal cytopenia after CAR-T cell therapy in patients with multiple myeloma or…
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma [Phase 1]
A Phase 1 trial evaluating EBV-specific cytotoxic T lymphocytes for Epstein-Barr virus–associated lymphomas, currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Ultrasound to Detect Splenomegally in Patients With Isolated Thrombocytopenia
A clinical trial update describes research using ultrasound to detect splenomegaly in patients with isolated thrombocytopenia, including pri…
-
CLINICAL_TRIALS trial_result · 2020-08-03Clinical Trial Update: Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer [Phase 3]
Phase 3 trial comparing darbepoetin alfa with epoetin alfa for treating anemia in patients undergoing chemotherapy for cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-07-27Clinical Trial Update: Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial [Phase 3]
Phase 3 clinical trial update focusing on personalized or basic information to aid decision-making for participating in a trial.
-
CLINICAL_TRIALS trial_result · 2019-02-26Clinical Trial Update: Vaccine Therapy For Patients Being Considered For Organ Transplant Who Are at Risk For PTLD [Phase 1]
Phase 1 trial update of a vaccine therapy for organ transplant candidates at risk for post-transplant lymphoproliferative disorder (PTLD); s…
-
CLINICAL_TRIALS safety_alert · 2017-04-17Clinical Trial Update: Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone
Clinical trial update reports methemoglobinemia risk in young patients with hematologic cancers or aplastic anemia treated with dapsone in a…
-
CLINICAL_TRIALS trial_result · 2017-03-24Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant [Phase 2]
Phase 2 trial evaluating donor stem cell transplantation for patients with relapsed hematologic malignancies or secondary myelodysplasia who…
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy [Phase 2]
Phase 2 trial evaluating epoetin alfa or darbepoetin alfa for chemotherapy-induced anemia; results from a completed study were posted in 201…
-
CLINICAL_TRIALS trial_result · 2016-12-08Clinical Trial Update: Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer [Phase 3]
Phase 3 trial comparing nutritional supplements to prevent weight loss in cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2014-08-06Clinical Trial Update: American Ginseng in Treating Patients With Fatigue Caused by Cancer [Phase 3]
A phase 3 trial evaluating American ginseng for cancer-related fatigue has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2014-01-30Clinical Trial Update: Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma [Phase 1]
A Phase 1 trial evaluating imetelstat in pediatric patients with refractory or recurrent solid tumors or lymphoma has completed. The update …
-
CLINICAL_TRIALS trial_result · 2014-01-17Clinical Trial Update: Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation [Phase 2]
Phase 2 trial evaluating cyclophosphamide, rituximab, and prednisone or methylprednisolone for lymphoproliferative disease after solid organ…
-
CLINICAL_TRIALS trial_result · 2013-12-13Clinical Trial Update: Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation [Phase 2]
Phase 2 trial evaluating sirolimus, tacrolimus, thymoglobulin, and rituximab as graft-versus-host-disease prophylaxis in haploidentical and …
-
CLINICAL_TRIALS research · 2013-09-17Clinical Trial Update: AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma [Phase 1]
This Phase 1 clinical trial investigates AMG 706 in combination with gemcitabine for patients with advanced solid tumors or lymphoma.
-
CLINICAL_TRIALS research · 2013-02-20Clinical Trial Update: Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating infusion of donor-derived natural killer cells after donor stem cell transplant for various …
-
CLINICAL_TRIALS trial_result · 2012-10-04Clinical Trial Update: Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer [Phase 2]
Phase 2 trial evaluating epoetin alfa for treating chemotherapy-induced anemia in cancer patients; the study has completed.
-
CLINICAL_TRIALS trial_result · 2012-03-16Clinical Trial Update: Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma [Phase 1]
A Phase 1 clinical trial evaluating vandetanib in combination with bevacizumab in adults with advanced solid tumors or lymphoma has complete…
-
CLINICAL_TRIALS trial_result · 2012-02-28Clinical Trial Update: Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer [Phase 1]
Phase 1 trial update for a vaccine therapy targeting Epstein-Barr virus–related cancers; the study status is COMPLETED.
-
CLINICAL_TRIALS trial_result · 2011-03-02Clinical Trial Update: KX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to Treatment [Phase 1]
Phase 1 clinical trial update on KX2-391 in patients with advanced solid tumors or lymphoma that did not respond to prior treatment.